Big Pharma Split Corp A Shares PRM.TO
16.10 CAD +0.94 (+6.20%)
Nov 5, 2026, 10:03 AM EST
16.00 Day range 16.10
12.21 52-week range 16.10
- YTD
- +15.74%
- 1 year
- +31.86%
- Market cap
- 21.14M
- Revenue (ttm)
- 320.82K
- Profit margin
- -201.16%
- EPS (ttm)
- -1.95
- Shares out
- 1.13M
- Dividend
- 1.24
- Ex-dividend date
- Jun 27, 2024
- YTD return
- +15.74%
- 1-year return
- +31.86%
- Volume
- 2.94K
- Avg volume
- 1.47K
- Open
- 16.00
- Previous close
- 15.16
- Day's range
- 16.00 – 16.10
- 52-week range
- 12.21 – 16.10
- Beta
- 0.88
1Y +3.85 (+31.43%)
Key statistics
- Enterprise value
- 26.44M
- PEG ratio
- 0.00
- Price / sales
- 46.70
- Price / book
- 0.95
- Dividend yield
- 8.81%
- Payout ratio
- 78.30%
- Revenue growth
- -76.40%
- Free cash flow
- 4.09M
- Total cash
- 204.19K
- Total debt
- 10.30M
- Return on equity
- -3.63%
- Short % of float
- 0.00%
- 50-day average
- 13.42
- 200-day average
- 14.03
Next earnings
Consensus EPS estimate 0.00.
About Big Pharma Split Corp A Shares
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- Canada
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PRM.TO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Kovacs, L Michael | Director of Issuer | Acquisition or disposition in the public market | Oct 6, 2019 | 0 |